Maynard Um
-
-
-
-
-
-
-
Rallybio sells REV102 program to Recursion for up to $25 million
-
-
-
-
-
-
-
Rallybio Corporation (RLYB) to Discontinue Development of RLYB212 for Prevention of FNAIT
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Rallybio Corp. (RLYB)
-
-
-
-
-
-
448,143 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

